NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/04/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization3,513.6 mln
Float261 mln
Earnings Date08/11/2026
EPS
0.93
Decent
P / E
14.41
Fair value
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.69
Likely reliable
1-Year Forecast
11.25
Downside risk
Relative Strength
28
/ 100
Underperforming
Business Description
Organon & Co. is a global healthcare company founded in 1923 and based in Jersey City, New Jersey, that focuses primarily on women's health while also offering a broad range of other medical products. Its women's health lineup includes contraceptive implants, vaginal rings, daily pills, fertility treatments, and products addressing postpartum bleeding and bacterial infections. Beyond women's health, the company sells biosimilar versions of established medicines used in immunology and oncology, along with treatments for heart disease, high blood pressure, asthma, allergies, skin conditions, bone loss, and pain. Organon serves a wide network of customers worldwide, including pharmacies, hospitals, clinics, and government health programs.
